← FDA Drug Approvals (Drugs@FDA)

EVOTAZ

NDA · New Drug Application · Sponsor: BRISTOL · Approved 2015-01-29

Drug application

FDA Application #

NDA206353

Application type

New Drug Application

Brand name

EVOTAZ

Generic name

ATAZANAVIR AND COBICISTAT

Active ingredients

ATAZANAVIR SULFATE; COBICISTAT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL

Manufacturer

E.R. Squibb & Sons, L.L.C.

First approval

2015-01-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown